Chitosan microparticles: Influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound

Drug Development and Industrial Pharmacy

Volumn 40, Issue 11, 2014, Pages 1476-1482

  Piccirilli, Gisela N ^a   García, Agustina ^a,b   Leonardi, Darío ^a,b   Mamprin, María E ^b   Bolmaro, Raúl E ^c   Salomón, Claudio J ^a,b   Lamas, María C ^a,b  

^a Universidad Nacional de Rosario   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c INSTITUTO DE FÍSICA ROSARIO   (Argentina)

Author keywords

Albendazole; Bioavailability; Chitosan; Dissolution rate; Microparticles

Indexed keywords

ALBENDAZOLE; CHITOSAN; DODECYL SULFATE SODIUM; ANTHELMINTIC AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; GELATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; MICROENCAPSULATION; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY POWDER DIFFRACTION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; PARTICLE SIZE; PHARMACEUTICS; POWDER DIFFRACTION; WISTAR RAT;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; CHITOSAN; DRUG LIBERATION; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POWDER DIFFRACTION; RATS; RATS, WISTAR; SODIUM DODECYL SULFATE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL;

EID: 84911481054     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.829486     Document Type: Article

References (41)

1. Horton J. Albendazole: a broad spectrum anthelminthic for treatment of individuals and populations. Curr Opin Infect Dis 2002;15:599-608
2. Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 2003;86: 141-59
3. Pourgholami MH, Woon L, Almajd R, et al. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett 2001;165:43-9
4. Pourgholami MH, Akhter J, Wang L, et al. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol 2005;55:425-32
5. Mwambete KD, Torrado S, Cuesta-Bandera C, et al. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm 2004;272:29-36
6. Kalaiselvan R, Mohanta GP, Madhusudan S, et al. Enhancement of bioavaliability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques. Pharmazie 2007;62:604-7
7. Torrado S, Torrado S, Torrado JJ, Cadórniga R. Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 1996;140:247-50
8. Castro SG, Sanchez Bruni S, Lanusse CE, et al. Improved albendazole dissolution rate in pluronic 188 solid dispersions. AAPSPharmSciTech 2010;11:1518-25
9. Panwar P, Pandey B, Lakhera PC, Singh KP. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine 2010;5:101-8
10. Torrado S, Torrado S, Cadorniga R, Torrado JJ. Formulation parameters of albendazole solution. Int J Pharm 1996;140:45-50
11. Castillo JA, Palomo-Canales J, Garcia JJ, et al. Preparation and characterization of albendazole b-cyclodextrin complexes. Drug Dev Ind Pharm 1999;25:1241-8
12. Palomares-Alonso F, González CR, Bernad-Bernad MJ, et al. Two novel ternary albendazole-cyclodextrin-polymer systems: dissolution, bioavailability and efficacy against Taenia crassiceps cysts. Acta Trop 2010;113:56-60
13. Kas HS. Chitosan: properties, preparation and application to microparticulate systems. J Microencapsul 1997;14:689-711
14. Čalija B, Milić J, Cekić N, et al. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-Alginate microparticles with improved pH sensitivity. Drug Dev Ind Pharm 2013;39:77-88
15. Taha MO, Nasser W, Ardakani A, AlKhatib HS. Sodium lauryl sulfate impedes drug release from zinc-crosslinked alginate beads: switching from enteric coating release into biphasic profiles. Int J Pharm 2008;350:291-300
16. Desai KG, Park HJ. Preparation of cross-linked chitosan microspheres by spray drying: effect of cross-linking agent on the properties of spray dried microspheres. J Microencapsulation 2005; 22:377-95
17. Desai KG, Park HJ. Preparation and characterization of drug-loaded chitosan-Tripolyphosphate microspheres by spray drying. Drug Dev Research 2005;64:114-28
18. Simi SP, Saraswathi R, Sankar C, et al. Formulation and evaluation of albendazole microcapsules for colon Delivery using chitosan. Asian Pacific J Trop Med 2010;3:374-8
19. Wang F, Li P, Zhang J, et al. A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery. Drug Dev Ind Pharm 2010;36:867-77
20. Jain SK, Rai G, Saraf DK, Agrawal GP. The preparation and evaluation of albendazole microspheres for colonic delivery. Pharm Tech 2004;12:66-71
21. Rai G, Jain SK, Agrawal S, et al. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery. Die Pharmazie 2005;60:131-4
22. Gómez-Gaete C, Bustos L, Godoy R, et al. Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles. Drug Dev Ind Pharm 2013;39: 310-20
23. Stulzer HK, Piazzon Tagliari M, Parize AL, et al. Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying. Mater Sci Eng C 2009;29:387-92
24. He P, Davis SS, Illum L. Chitosan microspheres prepared by spray drying. Int J Pharm 1999;187:53-65
25. Alanazi FK, El-Badry M, Ahmed MO, Alsarra IA. Improvement of albendazole dissolution by preparing microparticles using spraydrying technique. Sci Pharm 2007;75:63-79
26. Leonardi D, Lamas MC, Olivieri A. Multiresponse optimization of the properties of albendazole-chitosan microparticles. J Pharm Biomed Anal 2008;48:802-7
27. United States Pharmacopeia and National Formulary, USP 30-NF 25. Rockville (MD): The United States Pharmacopeial Convention; 2007
28. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33
29. Kitzman D, Cheng KJ, Fleckenstein L. HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. J Pharm Biomed Analysis 2002;30:801-13
30. Claro de Souza M, Maldonado Marchetti J. Development of albendazole sulfoxide loaded eugragit microparticles. A potencial strategy to improve the drug bioavailability. Adv Powder Tech 2012; 23:801-7
31. Elsayed A, Al-Remawi M, Qinna N, et al. Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. AAPS PharmSciTech 2011;12:958-64
32. Wang F, Li P, Zhang J, et al. A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery. Drug Dev Ind Pharm 2010;36:867-77
33. Ma B, Li X, Qin A, He C. Chitosan/alginate complexes for vaginal delivery of chlorhexidine digluconate. Carbohydr Polym 2013;91: 651-8
34. Van De Velde K, Kiekens P. Structure analysis and degree of substitution of chitin, chitosan and dibutyrylchitin by FT-IR spectroscopy and solid state 13C NMR. Carbohydr Polym 2004; 58:409-16
35. Vasconcellos FC, Goulart G, Beppu MM. Production and characterization of chitosan microparticles containing papain for controlled release applications. Powder Tech 2011;205:65-70
36. Kockisch S, Rees GR, Tsibouklis J, Smart JD. Mucoadhesive, triclosan-loaded polymer microspheres for application to the oral cavity: preparation and controlled release characteristics. Eur J Pharm Biopharm 2005;59:207-16
37. Rekha MR, Sharma CP. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin Delivery and absorption. J Control Release 2009;135:134-41
38. Rane YM, Mashru RC, Sankalia MG, et al. Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approach. Drug Dev Ind Pharm 2007;33: 1008-23
39. Itoha K, Hirayamaa T, Takahashia A, et al. In situ gelling pectin formulations for oral drug delivery at high gastric pH. Int J Pharm 2007;335:90-6
40. Lankalapalli SS, Kolapalli RM. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya-chitosan polyelectrolyte complexes. Drug Dev Ind Pharm 2012;38:815-24
41. Onishi H, Koyama K, Sakata O, Machida Y. Preparation of chitosan/ alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats. Drug Dev Ind Pharm 2010;36:879-84